Orthopaedic Reconstruction
"Smith & Nephew gets well-deserved recognition in the industry for having best-in-class products and best-in-class employees who strive for excellence in everything we do. Breakthrough products and a best-in-class attitude will continue to set us apart from the competition and drive sales and revenue growth."
Andrew Holman
Orthopaedic Reconstruction
General Manager
Americas
|
Smith & Nephew has a clear, five-year strategic plan
for achieving that goal
We will reach our destination by engaging the very best professionals and focusing on following three primary paths to total customer satisfaction.
- Innovation: Consistently deliver new value to surgeons and patients.
- Focused growth. Exceed market growth rates with a continuum of breakthrough products that retain, restore, replace and rebuild joints.
- Operational excellence: Lead the way through strategic decision making and organizational alignment that maximizes growth and profits.
As part of our sales team, you'll be a central part of that strategy.
Look ahead: A new way to travel, a new road to the goal
Let's move on and up together
Hip resurfacing is estimated to be a $300 million US market; we're #1 there, and a leader in knees. Our sales goals are ambitious. The challenges will be there. Yet we are confident that we will achieve market superiority in this segment.
We see the signs—well before we get there
The numbers of aging Americans and active, informed 40-65 patients continue to grow. And Smith & Nephew is there ... with leading-edge technological advances that equip surgeons for a new age in orthopaedic reconstruction. There, training the most distinguished surgeons, at the most prestigious institutions. There, helping surgeons deliver positive patient experiences. There, at the forefront of a dramatically expanding, $10 billion global industry.
|
